Clinical Trial: Evaluation of Dipyridamole in Preventing Post-Transplant Hypophosphatemia in Kidney Transplant Recipients

U.S., Feb. 14 -- ClinicalTrials.gov registry received information related to the study (NCT06824454) titled 'Evaluation of Dipyridamole in Preventing Post-Transplant Hypophosphatemia in Kidney Transplant Recipients' on Feb. 07.

Brief Summary: The primary goal is to determine if Dipyridamole can improve serum phosphate levels and reduce the need for phosphate supplementation.

Study Start Date: March, 2025

Study Type: INTERVENTIONAL

Condition: Hypophosphatemia Kidney Transplantation

Intervention: DRUG: Dipyridamole 75 MG

Dipyridamole administered three times daily when serum phosphorus levels fall below 4 mg/dL. The drug is used off-label for this study to manage hypophosphatemia in kidney transplant recipients.

Recruitment Status: N...